BIOCYTOGEN PHARMACEUTICALS (BEIJING) CO., LTD. |
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 9.76 CNY | +0.31% |
|
+2.09% | -18.53% |
| 05-06 | Biocytogen Enters into Evaluation and Potential Licensing Agreement with Biocopy for TCR-mimic Antibodies | CI |
| 04-26 | Biocytogen Pharmaceuticals' Loss Narrows in 2023 | MT |
Chart calendar Biocytogen Pharmaceuticals (Beijing) Co., Ltd.
951f2836f66236a0b10231b1b256e5f1.f2CngMcH37J6JadQygE7856xKJmKHZMgIeyvKJ38axk.NAaRz68_tes7bv0qnERJwtyAXd_IXsNLFbvsa9WwMkAVKZWtgEyS4E5CyA~f5c32474dc2801305febf0d5f35c3e33
Past events on Biocytogen Pharmaceuticals (Beijing) Co., Ltd.
| 26/03/2024 | Q4 2023 Earnings Release |
| 03/11/2023 | Society for Immunotherapy of Cancer Meeting - Poster Number: 18 |
| 03/11/2023 | Society for Immunotherapy of Cancer Meeting - Poster Number: 356 |
| 03/11/2023 | Society for Immunotherapy of Cancer Meeting - Poster Number: 1168 |
| 03/11/2023 | Society for Immunotherapy of Cancer Meeting - Poster Number: 1164 |
| 03/11/2023 | Society for Immunotherapy of Cancer Meeting - Poster Number: 1150 |
| 03/11/2023 | Society for Immunotherapy of Cancer Meeting - Poster Number: 16 |
| 03/11/2023 | Society for Immunotherapy of Cancer Meeting - Poster Number: 12 |
| 03/11/2023 | Society for Immunotherapy of Cancer Meeting - Poster Number: 1152 |
| 02/11/2023 | Society for Immunotherapy of Cancer Meeting - Poster Number: 17 |
| 02/11/2023 | Society for Immunotherapy of Cancer Meeting - Poster Number: 19 |
| 02/11/2023 | Society for Immunotherapy of Cancer Meeting - Poster Number: 11 |
| 02/11/2023 | Society for Immunotherapy of Cancer Meeting - Poster Number: 1163 |
| 02/11/2023 | Society for Immunotherapy of Cancer Meeting - Poster Number: 1153 |
| 02/11/2023 | Society for Immunotherapy of Cancer Meeting - Poster Number: 13 |
| 02/11/2023 | Society for Immunotherapy of Cancer Meeting - Poster Number: 479 |
| 02/11/2023 | Society for Immunotherapy of Cancer Meeting - Poster Number: 1165 |
| 22/10/2023 | European Society for Medical Oncology Congress - Dr. Ben Markman |
| 27/08/2023 | Q2 2023 Earnings Release |
| 25/05/2023 03:00 | Annual General Meeting |
Annual results
| Fiscal Period | December | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
|
Net sales Million CNY | Released Forecast Spread | 355 | 534 556 -4.03% | 717 695 3.22% | 919 |
|
EBITDA Million CNY | Released Forecast Spread | 0,00 | -447 -231 -93.45% | -135 -148 8.43% | 83,1 |
|
EBIT Million CNY | Released Forecast Spread | 0,00 | -621 -473 -31.36% | -317 -326 2.65% | -98,4 |
|
Earnings before Tax (EBT) Million CNY | Released Forecast Spread | 0,00 | -601 -446 -34.83% | -380 -354 -7.39% | -89,0 |
|
Net income Million CNY | Released Forecast Spread | -546 | -602 -379 -58.82% | -383 -354 -8.18% | -89,0 |
|
EPS CNY | Released Forecast Spread | 0,00 | -1,58 -0,96 -64.58% | -0,96 -0,89 -7.87% | -0,22 |
| Announcement Date | 19/08/22 | 27/03/23 | 27/03/24 | - |
Quarterly results
| Fiscal Period | December | 2022 S2 | 2023 S1 | 2023 S2 | 2024 S1 | 2024 S2 |
|---|---|---|---|---|---|---|
|
Net sales Million CNY | Released Forecast Spread | 305 348 -12.35% | 327 314 4.14% | 390 368 6.08% | 397 | 527 |
|
EBIT Million CNY | Released Forecast Spread | -328 -130 -153.12% | -158 -166 5.19% | |||
| Announcement Date | 27/03/23 | 26/09/23 | 27/03/24 | - | - |
| 30/06/2024 | IMMUNOVANT, INC.: Q4 2024 Earnings Release (Projected) |
| 15/07/2024 06:45 | ADDLIFE AB: Q2 2024 Earnings Release |
| 21/07/2024 | MEDPACE HOLDINGS, INC.: Q2 2024 Earnings Release (Projected) |
| 23/07/2024 | SYNGENE INTERNATIONAL LIMITED: Q1 2025 Earnings Release (Projected) |
| 23/07/2024 | ALKERMES PLC: Q2 2024 Earnings Release (Projected) |
| 23/07/2024 | IQVIA HOLDINGS INC.: Q2 2024 Earnings Release (Projected) |
| 23/07/2024 | ICON PUBLIC LIMITED COMPANY: Q2 2024 Earnings Release (Projected) |
| 24/07/2024 | LONZA GROUP AG: Q2 2024 Earnings Release |
| 25/07/2024 06:00 | BACHEM HOLDING AG: Q2 2024 Earnings Release |
| 25/07/2024 | PHARVARIS N.V.: Q2 2024 Earnings Release (Projected) |
Past sector events for Biocytogen Pharmaceuticals (Beijing) Co., Ltd.
| 21/05/2024 | CUREVAC N.V.: Q1 2024 Earnings Release (Projected) |
| 21/05/2024 | EVOTEC SE: Q1 2024 Earnings Release |
| 21/05/2024 22:14 | ALVOTECH: Q1 2024 Earnings Release |
| 21/05/2024 12:00 | EXSCIENTIA PLC: Q1 2024 Earnings Release |
| 17/05/2024 07:00 | BIOARCTIC AB: Q1 2024 Earnings Release |
| 15/05/2024 21:05 | CULLINAN THERAPEUTICS, INC.: Q1 2024 Earnings Release |
| 14/05/2024 | GNI GROUP LTD.: Q1 2024 Earnings Release |
| 14/05/2024 21:05 | NUVATION BIO INC.: Q1 2024 Earnings Release |
| 14/05/2024 12:30 | ABSCI CORPORATION: Q1 2024 Earnings Release |
| 14/05/2024 06:50 | BELITE BIO, INC: Q1 2024 Earnings Release |
Net sales - Quarter - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- 2315 Stock
- Calendar Biocytogen Pharmaceuticals (Beijing) Co., Ltd.
